DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Krop IE, Kim SB, Gonzalez-Martin A. et al.
Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial.
Lancet Oncol 2014;
15: 689-699
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.